Table of contents
November 2003 - Volume 62 - suppl 2
Advances in targeted therapies V
Preface
- Advances in targeted therapies V (7 October, 2003)
Consensus statement
Clinical aspects
- Imaging: do erosions heal? (7 October, 2003)
Innate immunity
Regulation of the immune response
Update of IL1 and TNF blockade
- British Society for Rheumatology Biologics Register (7 October, 2003)
- Advances in targeted therapy: safety of biological agents (7 October, 2003)
New targets
- Metalloproteinases, inflammation, and rheumatoid arthritis (7 October, 2003)
- Role of interleukin 18 in rheumatoid arthritis (7 October, 2003)
- Angiogenesis as a target in rheumatoid arthritis (7 October, 2003)
- α4 Integrin blockade in inflammatory bowel disease(7 October, 2003)
Signal transduction in mesenchymal cells
- Signalling in osteoclasts and the role of Fos/AP1 proteins (7 October, 2003)
- Signal transduction networks in rheumatoid arthritis (7 October, 2003)
From animal models to new treatments in RA
- Rheumatoid arthritis in 2003: where are we now with treatment? (7 October, 2003)